Clinical evaluation of the newly formatted lateral‐flow device for invasive pulmonary aspergillosis

• DOI: 10.1111/myc.12704
• Publication Date: 2017-09-18T15:06:45Z
• Authors: Martin Hoenigl; Susanne Eigl; Sven Heldt; Wiebke Duettmann; Christopher Thornton; Juergen Prattes
• Keywords: Pulmonary aspergillosis

The study evaluated the newly formatted Aspergillus-specific lateral-flow-device (LFD), and compared its performance to original prototype "old" LFD test using BALF samples from 28 patients (14 with probable/proven invasive pulmonary aspergillosis [IPA] 14 no evidence for IPA). A total of 10/14 (71%) IPA resulted positive new LFD, including 8/9 true-positive 2/5 false-negative results old LFD. All without negative LFD; specificity was significantly improved